On Monday, Merck & Co Inc ( MRK ) and Moderna, Inc. ( MRNA ) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational individualized neoantigen therapy under development in combination with Keytruda (pembrolizumab) as adjuvant treatment for resectable Stage II, IIIA or IIIB (N2) non-small cell lung cancer (NSCLC) patients who did not...

01:13 PM EDT, 10/28/2024 (MT Newswires) -- Price: 89.11, Change: +1.86, Percent Change: +2.13 ...

12:52 PM EDT, 10/28/2024 (MT Newswires) -- Corus Entertainment fourth quarter results missed and the advertising outlook continues to look bleak with advertising market challenges and reprogramming risks, notes BMO. Quarterly revenue fell 21% (5% below expectations) while EBITDA was -9% (-0.5% below). Television advertising revenue declined -16%. Adj. EPS was -$0.02 vs. -$0.07 Street. BMO notes that the company...

12:45 PM EDT, 10/28/2024 (MT Newswires) -- AbbVie ( ABBV ) announced an agreement to buy Aliada Therapeutics and its Alzheimer's disease candidate for $1.4 billion in cash to boost its neuroscience portfolio. The pharmaceutical company will gain access to Aliada's lead investigational asset, ALIA-1758, which is an anti-pyroglutamate amyloid beta antibody being developed as a treatment for Alzheimer's. Shares...